简介:目的比较急性乙型肝炎、慢性乙型肝炎与慢性重型乙型肝炎患者HBVC蛋白和Pol蛋白特异性CTL表位变异的差异,以探讨乙型肝炎重症化和慢性化的可能机理。方法对516例乙型肝炎患者的血清进行HLA-A2和A11分型;用巢式PCR扩增血清HBVC基因与Pol基因并对PCR产物进行序列测定;根据HBVS基因序列,用VirusBlast软件鉴定患者感染的HBV基因型;用VectorNTI软件对目前已知的HLA-A2限制性的4个C蛋白和5个Pol蛋白特异性CTL表位与HLA-A11限制性的1个C蛋白表位进行序列分析。结果247例(47.86%)患者HLA-A2阳性,其中AHB67例,CHB109例,CSHB71例;220例(42.64%)患者HLA-A11阳性,其中AHB67例,CHB107例,CSHB46例;CTL表位变异分析结果如下:①在3组HLA-A2阳性患者,表位变异发生率无显著性差异(P〉0.05);②在三组HLA-A2阳性HBVB基因型患者,P455-463和P816-824表位变异有极显著性差异(P〈0.01);③在三组HLA-A2阳性HBVC基因型患者,各表位变异无显著性差异;④在三组HLA-A11阳性患者,C88-96表位变异发生率有显著性差异(P〈0.05),三组HBVC基因型患者,表位变异发生率有极显著性差异(P〈0.01),而在HBVB基因型患者,各表位变异无显著性差异(P〉0.05)。结论某些HBVC蛋白和Pol蛋白特异性CTL表位在AHB、CHB和CSHB患者间变异有明显差异,并且受感染病毒基因型的影响。CTL表位变异可能与乙型肝炎的重症化和慢性化机制相关。
简介:AIM:ToanalyzetheassociationbetweenHelicobacterspp.andsomecommongutbacteriainpatientswithcholecystitis.METHODS:Anested-polymerasechainreaction(PCR),specificto16SrRNAofHelicobacterspp.wasperformedonparaffin-embeddedgallbladdersamplesof100cholecystitisand102controlcases.ThesampleswerealsoanalyzedforsomecommongutbacteriabyPCR.Positivesamplesweresequencedforspeciesidentification.RESULTS:HelicobacterDNAwasfoundinsevenoutof100casesofacuteandchroniccholecystitis.SequenceanalysisdisplayedHelicobacterpullorum(H.pullorum)insixcasesandHelicobacterpyloriinone;H.pullorumwasonlyfoundincaseswithmetaplasia.Controlsam-pleswerenegativeforHelicobacterspp.andsomecommongutbacteria.Therewasasignificantdifference(P=0.007)betweencholecystitisandcontrolsamplesforHelicobacterDNA.CONCLUSION:ApossiblerelationshipwasdetectedbetweenHelicobacterDNAandcholecystitis.Furtherserologicalandimmunohistochemicalstudiesareneededtosupportthesedata.
简介:目的:我们通过服用西甲硅油联合链酶蛋白酶后胃镜下视野清晰度、检查时间及早癌检出率的变化,研究二者在早癌诊断中的应用价值。方法:选择我院门诊及住院接受胃镜检查的患者640例,随机分成研究者及对照组,每组320例。两组患者均在检查前10分钟口服10ml盐酸利多卡因胶浆,研究者在检查前20分钟加服链酶蛋白酶及西甲硅油。由内镜室高年资内镜医师进行胃镜检查,可疑病变活检送病理,比较两组患者胃镜检查时清晰度、检查时间、早期胃癌的检出率。结果:研究组视野清晰度A+B级达90%,对照组视野清晰度A+B级62.2%,两者比较差异有统计学意义(P<0.05),观察组操作时间为(6.05±1.59)min,常规组操作时间为(6.88±1.64)min,两者比较差异有统计学意义(P<0.05)),研究组早期胃癌的检出率45.4%,对照组早期胃癌的检出率22.2%,两组差异有统计学意义(P<0.05)。结论:西甲硅油联合链酶蛋白酶胃镜检查前口服可以使检查时的视野更加清晰,避免不良干扰.增加了内镜下诊断的准确性,提高了检查效率及早期胃癌的检出率,值得推广。
简介:肝炎B病毒(HBV)感染是使世界范围的3.5亿个人担心的一个全球公共健康问题。有长期的肝炎B(CHB)的个人在开发肝肝硬化,肝的补偿不全和hepatocellular癌的增加的风险。为了维持,无法发现的病毒的负担减少长期的感染复杂并发症。没有治疗,根除HBV感染。当前的药是昂贵的,与不利事件被联系,并且具有有限功效。当前的指南试着标准化临床的实践。不过,争吵与CHB关于无征状的病人的管理留下,并且什么是肝炎Be抗原(HBeAg)与正常丙氨酸aminotransferase积极是病毒的负担的截止价值区分HBeAg否定的CHB病人和不活跃的搬运人。我们详细讨论DNA水平为什么独自不是足够的开始CHB的治疗。
简介:AIM:TOinvestigatetheimmunogenicityofcandidateDNAvaccineagainsthepatitisCvirus(HCV)deliveredbytwoplasmidsexpressingHCVenvelopeprotein1(El)andenvelopeprotein2(E2)antigensrespectivelyandtostudytheeffectofCpGadjuvantonthiscandidatevaccine.METHODS:RecombinantplasmJdsexpressingHCVEIandE2antigensrespectivelywereusedtosimultaneouslyinoculatemicewithorwithoutCpGadjuvant.AntiserawerethencollectedandtJtersofantJ-HCVantibodieswereanalyzedbyELISA.Onemonthafterthelastinjection,animalsweresacrificedtopreparesingle-cellsuspensionofsplenocytes.ThesecellsweresubjectedtoHCVantigenspecificproliferaionassaysandcytokinesecretionassaystoevaluatethecellularimmuneresponsesofthevaccinatedanimals.RESULTS:AntibodyresponsestoHCVEIandE2antigensweredetectedinvaccinatedanimals.AnimalsreceivingCpGadjuvanthadslightlylowertitersofanti-HCVantibodiesinthesera,whilethesplenocytesfromtheseanimalsshowedhigherHCV-antigenspecificproliferation.Analysisofcytokinesecretionfromthesplenocyteswasconsistentwiththeaboveresults.Whilenoantigen-specificIL-4secretionwasdetectedforallvaccinatedanimals,HCVantigen-specificINF-γ,secretionwasdetectedforthesplenocytesofvaccinatedanimals.CpGadjuvantenhancedthesecretionofINF-γ,butdidnotchangetheprofileofIL-4secretion.CONCLUSION:VaccinationofmicewithplasmidsencodingHCVE1andE2antigensinduceshumoralandcellularimmuneresponses.CpGadjuvantsignificantlyenhancesthecellularimmuneresponse.
简介:AIM:NitrativeandoxidativeDNAdamagesuchas8-nitroguanineand8-oxo-7,8-dihydro-2'-deoxyguanosine(8-oxodG)formationhasbeenimplicatedininitiationand/orpromotionofinflammation-mediatedcarcinogenesis.TheaimofthisstudyistoclarifywhethertheseDNAlesionsparticipateintheprogressionofintrahepaticcholangiocarcinoma.METHODS:Weinvestigatedtherelationoftheformationof8-nitroguanineand8-oxodGandtheexpressionofhypoxia-induciblefactor-1α(HIF-1α)withtumorinvasionin37patientswithintra-hepaticcholangiocarcinoma.RESULTS:Immunohistochemicalanalysesrevealedthat8-nitroguanineand8-oxodGformationoccurredtoamuchgreaterextentincanceroustissuesthaninnon-canceroustissues.HIF-1αcouldbedetectedincanceroustissuesinallpatients,suggestinglowoxygentensioninthetumors.HIF-1αexpressionwascorrelatedwithinduciblenitricoxidesynthase(iNOS)expression(r=0.369andP=0.025)and8-oxodGformation(r=0.398andP=0.015).DoubleimmunofluorescencestudyrevealedthatiNOSandHIF-1αco-localizedincanceroustissues.Notably,theformationof8-oxodGwascorrelatedsignificantlywithlymphaticinvasion(r=0.386andP=0.018).Moreover,8-nitroguanineand8-oxodGinnon-canceroustissueswereassociatedsignificantlywithneuralinvasion(P=0.042andP=0.026,respectively).TheseresultssuggestthatreciprocalactivationbetweenHIF-1αandiNOSmediatespersistentDNAdamage,whichinducestumorinvasivenessviamutations,resultinginpoorprognosis.CONCLUSION:Theformationof8-nitroguanineand8-oxodGplaysanimportantroleinmultiplestepsofgeneticchangesleadingtotumorprogression,includinginvasiveness.
简介:AIM:Toanalyzethemismatchrepair(MMR)statusandtheARID1Aexpressionaswellastheirclinicopathologicalsignificanceingastricadenocarcinomas.METHODS:WeexaminedtheexpressionsofMMRproteinsandARID1Abyimmunohistochemistryinconsecutive489primarygastricadenocarcinomas.Theresultswerefurthercorrelatedwithclinicopathologicalvariables.RESULTS:ThelossofanyMMRproteinexpression,indicativeofMMRdeficiency,wasobservedin38cases(7.8%)andwassignificantlyassociatedwithanolderage(68.6±9.2vs60.4±11.7,P<0.001),afemalesex(55.3%vs31.3%,P=0.004),anantrallocation(44.7%vs25.7%,P=0.021),andadifferentiatedhistology(57.9%vs39.7%,P=0.023).AbnormalARID1Aexpression,includingreducedorlossofARID1Aexpression,wasobservedin109cases(22.3%)andwassignificantlycorrelatedwithlymphaticinvasion(80.7%vs69.5%,P=0.022)andlymphnodemetastasis(83.5%vs73.7%,P=0.042).ThetumorswithabnormalARID1AexpressionmorefrequentlyindicatedMMRdeficiency(47.4%vs20.2%,P<0.001).AmultivariateanalysisidentifiedabnormalARID1Aexpressionasanindependentpoorprognosticfactor(HR=1.36,95%CI:1.01-1.84;P=0.040).CONCLUSION:OurobservationssuggestthattheAIRD1Ainactivationisassociatedwithlymphaticinvasion,lymphnodemetastasis,poorprognosis,andMMRdeficiencyingastricadenocarcinomas.
简介:目的观察HBsAg阳性患者血清标记物与HBVDNA水平间的关系.方法用时间分辩免疫荧光分析法测定HBV感染者的血清标记物,荧光定量PCR法测定HBVDNA含量.结果204例HBV感染者中,血清标记物出现三种组合,组合Ⅰ为HBsAg(+)、HBeAg(+)、抗-HBc(+)104例,血清HBVDNA阳性率为86.5%;组合Ⅱ为HBsAg(+)、抗-HBe(+)、抗-HBc(+)80例,血清HBVDNA阳性率为32.5%;组合Ⅲ为HBsAg(+)、抗-HBc(+)20例,血清HBVDNA含量均低于检测低限(<1×103拷贝/毫升).结论HBV感染者血清HBVDNA水平更能反映病毒复制的程度,应努力开展此项检测.
简介:DNA/miRNA基因甲基化作为一种新的结直肠癌非侵入性筛查标志物,被证实具有较高的敏感性和特异性,目前有大量有关检测血液、粪便中DNA/miRNA基因异常甲基化筛查结直肠癌的研究,但仅有个别商业化的甲基化基因试剂盒小规模应用于临床实践。本人将对目前有关检测血液/粪便中DNA/miRNA基因异常甲基化筛查结直肠癌的国内外研究进行综述,总结其潜在的临床价值。
简介:目的探讨乙型肝炎患者血清学标志(HBVM)与HBVDNA的关系.方法对257例乙型肝炎患者同时检测HBVM与HBVDNA.HBVM检测用ELISA法,HBVDNA检测用PCR法.根据不同检测结果进行对比分析.结果在HBsAg+HBeAg+HBcAb阳性的血清中HBVDNA阳性率和含量最高,血清HBeAg与HBVDNA含量密切相关,但部分HBeAg阴性或抗-HBe阳性患者也有较高的HBVDNA阳性率及含量.结论PCR定量检测HBVDNA含量更有助于判断体内HBV复制的情况及传染性强弱,在临床上有重要意义.
简介:目的探讨长期服用阿德福韦酯对CHB患者外周血单个核细胞(PBMCs)线粒体的可能损伤。方法本研究包括18例服用阿德福韦酯2年、25例服用3年和22例未服用阿德福韦酯的CHB患者;采用实时定量PCR法检测各组患者PBMCs中线粒体DNA(mtDNA)含量(mtDNA/nDMA);采用ELISA法检测血浆丙二醛(MDA)、F2一isoprostanes含量;采用分光光度法检测血浆总抗氧化能力(TAOC)。结果2年组患者mtDNA含量为0.6±0.4copies/cell,3年组为0.8±0.5copies/cell,均显著低于对照组(1.4±1.2copies/cell,P均〈0.05);2年组F2一iso—prostanes含量为1.5±0.8ng/ml,3年组为2.2士1.3ng/ml,显著低于对照组(3.7±2.7ng/ml,P均〈0.05);2年组TAOC含量为3.0±1.1单位/毫升,3年组为2.3±1.4单位/毫升,显著低于对照组(4.3±1.8单位/毫升,P均〈0.05)。3组问MDA含量无统计学差异(F=2.404,P〉0.05)。结论长期应用阿德福韦酯治疗慢性乙型肝炎,对PBMCs中mtDNA水平有一定的影响,其意义还有待探讨。
简介:探讨慢性乙型肝炎轻度患者血清HBVDNA载量与肝组织病理学变化的关系。方法根据血清HBeAg状态将310例慢性乙型肝炎轻度患者分为HBeAg阳性和HBeAg阴性,应用荧光定量PCR技术检测血清HBVDNA水平,常规进行肝活检术和病理学观察,分析血清HBVDNA载量与肝组织病理学变化的关系。结果224例HBeAg阳性患者肝组织炎症程度以G0(42.0%)为主,纤维化程度以S0(58.0%)为主;86例HBeAg阴性患者炎症程度以G0(29.1%)、G1(30.2%)、G2(34.9%)为主,纤维化程度以S0(51.2%)为主;HBeAg阳性患者血清HBVDNA水平与肝组织炎症程度无明显相关(r=-0.098,P>0.05),与纤维化分期间存在负相关关系(r=-0.309,P<0.01);HBeAg阴性患者血清HBVDNA水平与肝组织炎症程度存在正相关关系(r=0.306,P<0.01),与纤维化程度无明显相关(r=0.112,P>0.05)。结论HBeAg阳性与HBeAg阴性患者血清HBVDNA载量与肝组织病理学变化的关系存在显著差别,应区别分析其临床意义。